A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo
- PMID: 20371804
- PMCID: PMC6632783
- DOI: 10.1523/JNEUROSCI.5825-09.2010
A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo
Abstract
Although amyloid beta (Abeta) oligomers are presumed to cause synaptic and cognitive dysfunction in Alzheimer's disease (AD), their contribution to other pathological features of AD remains unclear. To address the latter, we generated APP transgenic mice expressing the E693Delta mutation, which causes AD by enhanced Abeta oligomerization without fibrillization. The mice displayed age-dependent accumulation of intraneuronal Abeta oligomers from 8 months but no extracellular amyloid deposits even at 24 months. Hippocampal synaptic plasticity and memory were impaired at 8 months, at which time the presynaptic marker synaptophysin began to decrease. Furthermore, we detected abnormal tau phosphorylation from 8 months, microglial activation from 12 months, astrocyte activation from 18 months, and neuronal loss at 24 months. These findings suggest that Abeta oligomers cause not only synaptic alteration but also other features of AD pathology and that these mice are a useful model of Abeta oligomer-induced pathology in the absence of amyloid plaques.
Figures
Similar articles
-
New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.Sci Rep. 2019 Nov 22;9(1):17368. doi: 10.1038/s41598-019-53415-8. Sci Rep. 2019. PMID: 31757975 Free PMC article.
-
Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.Life Sci. 2012 Dec 10;91(23-24):1169-76. doi: 10.1016/j.lfs.2011.12.022. Epub 2012 Jan 17. Life Sci. 2012. PMID: 22273754
-
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.PLoS One. 2020 Sep 23;15(9):e0239584. doi: 10.1371/journal.pone.0239584. eCollection 2020. PLoS One. 2020. PMID: 32966331 Free PMC article.
-
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714. Curr Alzheimer Res. 2016. PMID: 26567742 Review.
-
Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.Acta Neuropathol. 2010 May;119(5):523-41. doi: 10.1007/s00401-010-0679-9. Epub 2010 Mar 31. Acta Neuropathol. 2010. PMID: 20354705 Free PMC article. Review.
Cited by
-
A novel mouse model for N-terminal truncated Aβ2-x generation through meprin β overexpression in astrocytes.Cell Mol Life Sci. 2024 Mar 13;81(1):139. doi: 10.1007/s00018-024-05139-w. Cell Mol Life Sci. 2024. PMID: 38480559
-
Aβ∗56 is a stable oligomer that impairs memory function in mice.iScience. 2024 Feb 15;27(3):109239. doi: 10.1016/j.isci.2024.109239. eCollection 2024 Mar 15. iScience. 2024. PMID: 38433923 Free PMC article.
-
Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology.EMBO Rep. 2024 Mar;25(3):1233-1255. doi: 10.1038/s44319-024-00090-0. Epub 2024 Feb 27. EMBO Rep. 2024. PMID: 38413732 Free PMC article.
-
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2. Mol Neurodegener. 2024. PMID: 38378578 Free PMC article. Review.
-
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change.Acta Neuropathol. 2024 Feb 14;147(1):40. doi: 10.1007/s00401-024-02691-4. Acta Neuropathol. 2024. PMID: 38353753 Free PMC article.
References
-
- Arendt T. Neurodegeneration and plasticity. Int J Dev Neurosci. 2004;22:507–514. - PubMed
-
- Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675–688. - PubMed
-
- Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal. 1996;13:159–163. - PubMed
-
- Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model. Am J Pathol. 2004;165:1289–1300. - PMC - PubMed
-
- Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puoliväli J, Lesné S, Ashe KH, Muchowski PJ, Mucke L. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem. 2007;282:23818–23828. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases